Navigator Medicines

Funding and NIH signals

• SEC Form D raise Raised $10M (Form D filed Sep 25, 2026). SEC Form D 0002035715-26-000005 (Sep 25, 2026)
  Evidence (1 event)

  • Sep 25, 2026 · SEC Form D 0002035715-26-000005
    Name of Issuer: Navigator Medicines, Inc.; CIK: 2035715; Address: San Mateo, CA; Submission type: D; Filing date: 2026-09-25; Industry Group: Biotechnology; Date of First Sale: 2026-09-18; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 40000000; Total Amount Sold: 10000000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Raises and deals from press releases

• Raise Series A · $100M · announced Aug 27, 2024 Company release ↗
  Source quote

  • Aug 27, 2024 · Company release ↗
    “In connection with the transaction, Navigator has closed a $100M Series A financing, co-led by RA Capital Management and Forbion.”

Raises announced in these releases: $100M disclosed.

From the company’s own releases; this list is partial. All raises and deals